Woods, Arcadia
15  Ergebnisse:
Personensuche X
?
1

Development of new in vitro models of lung protease activit..:

Woods, Arcadia ; Andrian, Teodora ; Sharp, Gemma...
Woods , A , Andrian , T , Sharp , G , Bicer , E M , Vandera , K-K A , Patel , A , Mudway , I , Dailey , L A & Forbes , B 2020 , ' Development of new in vitro models of lung protease activity for investigating stability of inhaled biological therapies and drug delivery systems ' , EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS , vol. 146 , pp. 64 - 72 . https://doi.org/10.1016/j.ejpb.2019.11.005.  , 2020
 
?
2

Antibiotic-in-cyclodextrin-in-liposomes:formulation develop..:

Vandera, Kalliopi-Kelli A ; Picconi, Pietro ; Valero, Margarita...
Vandera , K-K A , Picconi , P , Valero , M , González-Gaitano , G , Woods , A , Zain , N M , Bruce , K , Clifton , L A , Skoda , M W A , Rahman , K M , Harvey , R D & Dreiss , C 2020 , ' Antibiotic-in-cyclodextrin-in-liposomes : formulation development and interactions with model bacterial membranes ' , Molecular Pharmaceutics , vol. 17 , no. 7 , pp. 2354-2369 . https://doi.org/10.1021/acs.molpharmaceut.0c00096.  , 2020
 
?
3

Development of new in vitro models of lung protease activit..:

Woods, Arcadia ; Andrian, Teodora ; Sharp, Gemma...
Woods , A , Andrian , T , Sharp , G , Bicer , E M , Vandera , K-K A , Patel , A , Mudway , I , Dailey , L A & Forbes , B 2020 , ' Development of new in vitro models of lung protease activity for investigating stability of inhaled biological therapies and drug delivery systems ' , EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS , vol. 146 , pp. 64 - 72 . https://doi.org/10.1016/j.ejpb.2019.11.005.  , 2020
 
?
4

Antibiotic-in-cyclodextrin-in-liposomes:formulation develop..:

Vandera, Kalliopi-Kelli A ; Picconi, Pietro ; Valero, Margarita...
Vandera , K-K A , Picconi , P , Valero , M , González-Gaitano , G , Woods , A , Zain , N M , Bruce , K , Clifton , L A , Skoda , M W A , Rahman , K M , Harvey , R D & Dreiss , C 2020 , ' Antibiotic-in-cyclodextrin-in-liposomes : formulation development and interactions with model bacterial membranes ' , Molecular Pharmaceutics , vol. 17 , no. 7 , pp. 2354-2369 . https://doi.org/10.1021/acs.molpharmaceut.0c00096.  , 2020
 
?
6

Mucus penetrating properties of soft, distensible lipid nan..:

Chen, Hanpeng ; Mansfield, Edward D. H ; Woods, Arcadia...
https://centaur.reading.ac.uk/82562/1/1-s2.0-S0939641118307914-main.pdf.  , 2019
 
?
7

Mucus penetrating properties of soft, distensible lipid nan..:

Chen, Hanpeng ; Mansfield, Edward D.H ; Woods, Arcadia...
Chen , H , Mansfield , E D H , Woods , A , Khutoryanskiy , V V , Forbes , B & Jones , S A 2019 , ' Mucus penetrating properties of soft, distensible lipid nanocapsules ' , EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS , vol. 139 , pp. 76-84 . https://doi.org/10.1016/j.ejpb.2019.02.020.  , 2019
 
?
8

Mucus penetrating properties of soft, distensible lipid nan..:

Chen, Hanpeng ; Mansfield, Edward D.H ; Woods, Arcadia...
Chen , H , Mansfield , E D H , Woods , A , Khutoryanskiy , V V , Forbes , B & Jones , S A 2019 , ' Mucus penetrating properties of soft, distensible lipid nanocapsules ' , EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS , vol. 139 , pp. 76-84 . https://doi.org/10.1016/j.ejpb.2019.02.020.  , 2019
 
?
9

Antimicrobial molecules in the lung:formulation challenges ..:

Woods, Arcadia ; Rahman, Khondaker Mirazur
Woods , A & Rahman , K M 2018 , ' Antimicrobial molecules in the lung : formulation challenges and future directions for innovation ' , Future Medicinal Chemistry , vol. 10 , no. 5 , pp. 575-604 . https://doi.org/10.4155/fmc-2017-0162.  , 2018
 
?
10

Antimicrobial molecules in the lung:formulation challenges ..:

Woods, Arcadia ; Rahman, Khondaker Mirazur
Woods , A & Rahman , K M 2018 , ' Antimicrobial molecules in the lung : formulation challenges and future directions for innovation ' , Future Medicinal Chemistry , vol. 10 , no. 5 , pp. 575-604 . https://doi.org/10.4155/fmc-2017-0162.  , 2018
 
?
11

Controlled drug release from lung-targeted nanocarriers via..:

Chen, Hanpeng ; Woods, Arcadia ; Forbes, Benjamin John.
Chen , H , Woods , A , Forbes , B J & Jones , S A 2016 , ' Controlled drug release from lung-targeted nanocarriers via chemically mediated shell permeabilisation ' , INTERNATIONAL JOURNAL OF PHARMACEUTICS , vol. 511 , no. 2 , pp. 1033–1041 . https://doi.org/10.1016/j.ijpharm.2016.08.012.  , 2016
 
?
12

Lung inflammation does not affect the clearance kinetics of..:

Patel, Aateka ; Woods, Arcadia ; Riffo-Vasquez, Yanira...
Patel , A , Woods , A , Riffo-Vasquez , Y , Babin-Morgan , A , Jones , M-C , Jones , S , Sunassee , K , Clark , S , de Rosales , R T M , Page , C , Spina , D , Forbes , B & Dailey , L A 2016 , ' Lung inflammation does not affect the clearance kinetics of lipid nanocapsules following pulmonary administration ' , JOURNAL OF CONTROLLED RELEASE , vol. 235 , pp. 24-33 . https://doi.org/10.1016/j.jconrel.2016.05.024.  , 2016
 
?
13

Lung inflammation does not affect the clearance kinetics of..:

Patel, Aateka ; Woods, Arcadia ; Riffo-Vasquez, Yanira...
Patel , A , Woods , A , Riffo-Vasquez , Y , Babin-Morgan , A , Jones , M-C , Jones , S , Sunassee , K , Clark , S , de Rosales , R T M , Page , C , Spina , D , Forbes , B & Dailey , L A 2016 , ' Lung inflammation does not affect the clearance kinetics of lipid nanocapsules following pulmonary administration ' , JOURNAL OF CONTROLLED RELEASE , vol. 235 , pp. 24-33 . https://doi.org/10.1016/j.jconrel.2016.05.024.  , 2016
 
?
14

Controlled drug release from lung-targeted nanocarriers via..:

Chen, Hanpeng ; Woods, Arcadia ; Forbes, Benjamin John.
Chen , H , Woods , A , Forbes , B J & Jones , S A 2016 , ' Controlled drug release from lung-targeted nanocarriers via chemically mediated shell permeabilisation ' , INTERNATIONAL JOURNAL OF PHARMACEUTICS , vol. 511 , no. 2 , pp. 1033–1041 . https://doi.org/10.1016/j.ijpharm.2016.08.012.  , 2016
 
1-15